A first-in-class, first-in-human phase I trial of KPT-330 (selinexor), a selective inhibitor of unclear export (SINE) in patients (pis) with advanced solid tumors Meeting Abstract


Authors: Mau-Soerensen, M.; Razak, A. R. A.; Shields, A. F.; Gabrail, N. Y.; Gerecitano, J. F.; Shacham, S.; Lassen, U. N.; Rashal, T.; Cooksoy, J.; Landosman, Y.; Pond, G.; Oza, A. M.; Kauffman, M.; Siu, L. L.; Bedard, P. L.; Mahaseth, H.; Mirza, M. R.; Mahipal, A.
Abstract Title: A first-in-class, first-in-human phase I trial of KPT-330 (selinexor), a selective inhibitor of unclear export (SINE) in patients (pis) with advanced solid tumors
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613202802
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.2537
Notes: Meeting Abstract: 2537 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors